Atherothrombosis: common factor in stroke, myocardial infarction and peripheral vascular disease

被引:0
作者
Haberl, RL [1 ]
Dembowski, K [1 ]
机构
[1] Krankenhaus Munchen Harlaching, Dept Neurol, D-81545 Munich, Germany
关键词
stroke; myocardial infarction; peripheral arterial disease; antithrombotic therapy; risk factors;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombosis superimposed on atherosclerosis causes approximately 60% of all brain infarctions. Patients with atherothrombotic occlusion of the cerebral vasculature are also at increased risk for occlusion within other vascular beds, as is suggested by the presence of similar risk factors for occlusive disease in the cerebral, cardiac and peripheral circulation. Because of this, there is a need for treatments that address a single occurrence of atherothrombosis, such as occlusion of the cerebral vessels, but which also provide effective protection against other potential occurrences of ischaemia throughout the body. Antithrombotic therapy is a key aspect of secondary treatment for patients who have experienced brain infarctions. Secondary prevention of a recurrent cerebral infarct may thus constitute primary prevention for both heart disease and peripheral arterial disease.
引用
收藏
页码:A41 / A44
页数:4
相关论文
共 50 条
  • [31] Stroke and myocardial infarction after herpes zoster
    Wutzler P.
    MMW - Fortschritte der Medizin, 2017, 159 (13) : 66 - 68
  • [32] Global Estimates Of Frequency And Outcomes Of Coronavirus Disease 2019 Associated Stroke And Myocardial Infarction
    Tannous, Jonika
    Pan, Alan
    Potter, Thomas
    Bako, Abdulaziz
    Meeks, Jennifer
    Baig, Eman
    Johnson, Carnayla
    Khan, Osman
    Vahidy, Farhaan S.
    STROKE, 2022, 53
  • [33] Immunosuppressive Treatments in Acute Myocardial Infarction and Stroke
    Raffaghello, Lizzia
    Bianchi, Giovanna
    Pistoia, Vito
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (01) : 59 - 67
  • [34] Ischemic stroke - Impact of a recent myocardial infarction
    Mooe, T
    Olofsson, BO
    Stegmayr, B
    Eriksson, P
    STROKE, 1999, 30 (05) : 997 - 1001
  • [35] The impact of peripheral artery disease on major adverse cardiovascular events following myocardial infarction
    Andersen, Patricia
    Kragholm, Kristian
    Torp-Pedersen, Christian
    Jensen, Svend Eggert
    Attar, Rubina
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 343 : 131 - 137
  • [36] Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry
    Uchiyama, Shinichiro
    Shibata, Yoshisato
    Hirabayashi, Takayuki
    Mihara, Ban
    Hamashige, Naohisa
    Kitagawa, Kazuo
    Goto, Shinya
    Origasa, Hideki
    Shimada, Kazuyuki
    Kobayashi, Hiroyuki
    Isozaki, Mitsuhiro
    Ikeda, Yasuo
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2010, 19 (03) : 190 - 197
  • [37] Beneficial Effects of Vaccination on Cardiovascular Events: Myocardial Infarction, Stroke, Heart Failure
    Fountoulaki, Katerina
    Tsiodras, Sotirios
    Polyzogopoulou, Eftychia
    Olympios, Christophoros
    Parissis, John
    CARDIOLOGY, 2018, 141 (02) : 98 - 106
  • [38] Health-Related Quality of Life in Patients with a History of Myocardial Infarction and Stroke
    Bach, Jan-Philipp
    Riedel, Oliver
    Pieper, Lars
    Klotsche, Jens
    Dodel, Richard
    Wittchen, Hans-Ulrich
    CEREBROVASCULAR DISEASES, 2011, 31 (01) : 68 - 76
  • [39] Oral contraceptives and cardiovascular disease: emerging evidence on potential associations with angina, myocardial infarction and stroke
    Victory, Rahi
    Diamond, Michael P.
    WOMENS HEALTH, 2005, 1 (01) : 133 - 145
  • [40] Outcomes Associated With Peripheral Artery Disease in Myocardial Infarction With Cardiogenic Shock
    Mihatov, Nino
    Mosarla, Ramya C.
    Kirtane, Ajay J.
    Parikh, Sahil A.
    Rosenfield, Kenneth
    Chen, Siyan
    Song, Yang
    Yeh, Robert W.
    Secemsky, Eric A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (13) : 1223 - 1235